An artificial intelligence is now allowed legally to participate in clinical decisions over prescription renewals. The approval, made in the US state of Utah, is a global first, the company behind the ...
InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...
A common confession is that AI partners don’t shame, mock, or weaponize vulnerability. Users say they can admit fears, ...
While Walz issued press statements specifying the policy and administrative decisions he has made to tackle fraud, and has ...
In a pair of guidance documents released Tuesday, the regulator clarified the types of wellness features and clinical ...
Driven Tele-Dermatoscope Market Report 2025" has been added to ResearchAndMarkets.com's offering. The AI-driven tele-dermatoscope market is experiencing notable growth, with projections indicating an ...
Abbott, the creator of continuous glucose monitors, launched the new Assist feature at CES 2026. Part of the Libre app, it ...
Phase 1 proof-of-concept study of CLY-124 in Sickle Cell Disease expected in Q4 2026 In vivo preclinical data assessing new compounds vs. standard of care in gold-standard, translatable myelofibrosis ...
Alpenglow Biosciences, the leader in clinical-grade 3D digital pathology and AI-powered spatial analytics, and PathNet, one of the nation's foremost pathology laboratories and largest independent ...
Ametris has expanded its work with the world's leading pharmaceutical companies through three partnership structures: evidence-generation collaborations, exclusive biomarker IP licensing engagements ...
It's. moreAI-infused than ever, but the Honor Magic 8 Pro's excellent rear cameras remain the true stars of the show ...
Leading AI device ecosystem company HONOR today announced the launch of the HONOR Magic8 Pro in the United Kingdom. Created ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results